Connect with us

/home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 153
">
Warning: Undefined array key 0 in /home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 153

Warning: Attempt to read property "cat_name" on null in /home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 153

Kerbal Space Program: Breaking Ground Expansion Now Available for PC

Published

on

Reading Time: 5 minutes

New robotic parts, deployed science, surface features, and more
provide exciting ways to explore space

NEW YORK–(BUSINESS WIRE)–Private
Division
and Squad
today announced that Kerbal
Space Program: Breaking Ground
Expansion

is now available for PC. Kerbal Space Program: Breaking
Ground Expansion
, the second expansion for the critically
acclaimed space sim, is an engaging, feature-rich content pack. This
expansion increases the objective possibilities once celestial bodies
have been reached by adding more interesting scientific endeavors and
expanding the toolset.

With Kerbal Space Program: Breaking Ground Expansion
players will have all new robotic parts that include hinges, rotors,
pistons, and more in a variety of different sizes. These parts encourage
the invention of deeply creative vehicles with further advanced
functionality than ever before.

Deployed science is another major addition of this expansion, which
enhances the experiments and data-collection objectives that have gone
hand-in-hand with space exploration. Players will be able to utilize a
storage container in their craft that can hold various pieces of science
equipment. Upon reaching their destination, players can deploy equipment
to monitor and collect data through assorted methods and relay it back
to Kerbin, the Kerbals’ home planet. One scientific instrument, the
active seismometer, even tasks players to deliberately crash
contraptions into a celestial body to gather seismic data!

Kerbal Space Program: Breaking Ground Expansion also
changes the experience players have when exploring celestial bodies. New
surface features are scattered across planets throughout the solar
system and can be scanned utilizing a new robotic arm attached to
rovers. These surface features include cryovolcanoes, meteors, craters,
and many more mysterious objects for players to investigate.
Additionally, the expansion includes a new futuristic
space suit for the Kerbals so they can travel space in style.

“We are always listening closely to the ever-expanding Kerbal
Space Program
Community, and Breaking Ground addresses
a long-requested aspect of the game that we have been working hard to
fulfill: compelling reasons to explore and research planets,” said
Nestor Gomez, Lead Producer at Squad. “Players now have even more
reasons to explore the celestial bodies of the solar system.”

“The creativity of the KSP community is something that never ceases to
amaze us,” said Michael Cook, Executive Producer at Private Division. “Kerbal
Space Program: Breaking Ground Expansion
is packed with content
that we believe will add countless hours of fresh gameplay, as well as
generate some incredible new craft designs from players. We can’t wait
to see what they come up with.”

About Kerbal Space Program

In Kerbal Space Program, players take charge of the space
program for the alien race known as the Kerbals, and have access to an
array of parts to assemble a fully functional spacecraft that flies (or
doesn’t) based on realistic aerodynamic and orbital physics. Launch your
Kerbal crew into orbit and beyond (while keeping them alive) to explore
moons and planets in the Kerbol solar system, constructing bases and
space stations to expand the reach of your expedition.

Kerbal Space Program features three gameplay modes. In
Science Mode, players can perform space experiments to unlock new
technology and advance the knowledge of Kerbalkind. In Career Mode, you
can oversee every aspect of the space program, including construction,
strategy, funding, upgrades, and more. In Sandbox, players can build any
spacecraft that they can think of, with all parts and technology in the
game.

Kerbal Space Program: Breaking Ground Expansion is now
available on PC for $14.99 (MSRP). Kerbal Space Program is
rated E for Everyone by the ESRB. For more information on Kerbal
Space Program
, subscribe on YouTube,
follow us on Twitter,
become a fan on Facebook,
and visit www.KerbalSpaceProgram.com.

Private Division is a publishing label of Take-Two Interactive Software,
Inc. (NASDAQ:TTWO).

About Squad

Based in Mexico City, Squad are the developers of the critically
acclaimed space simulation game, Kerbal Space Program. Comprised
of an international team of talented, passionate and ambitious
individuals that love videogames, space, and science, they have
reinvented themselves into full-time video game development.

About Take-Two Interactive Software

Headquartered in New York City, Take-Two Interactive Software, Inc. is a
leading developer, publisher and marketer of interactive entertainment
for consumers around the globe. The Company develops and publishes
products principally through its wholly-owned labels Rockstar Games and
2K, as well as its Private Division label and Social Point, a leading
developer of mobile games. Our products are designed for console systems
and personal computers, including smartphones and tablets, and are
delivered through physical retail, digital download, online platforms
and cloud streaming services. The Company’s common stock is publicly
traded on NASDAQ under the symbol TTWO. For more corporate and product
information please visit our website at http://www.take2games.com.

About Private Division

Private Division is a developer-focused publisher that empowers
independent studios to develop the games that they are passionate about
creating, while providing the support that they need to make their
titles critically and commercially successful on a global scale. The
label publishes Kerbal Space Program and will publish upcoming
titles with renowned creative talent at studios including The Outer
Worlds
from Obsidian Entertainment, Ancestors: The Humankind
Odyssey
from Panache Digital Games, an unannounced title from V1
Interactive, and more. Private Division is headquartered in New York
City with offices in Seattle, Las Vegas, and Munich. For more
information, please visit www.privatedivision.com.

All trademarks and copyrights contained herein are the property of their
respective holders.

Cautionary Note Regarding Forward-Looking
Statements

The statements contained herein which are not historical facts are
considered forward-looking statements under federal securities laws and
may be identified by words such as “anticipates,” “believes,”
“estimates,” “expects,” “intends,” “plans,” “potential,” “predicts,”
“projects,” “seeks,” “should,” “will,” or words of similar meaning and
include, but are not limited to, statements regarding the outlook for
the Company’s future business and financial performance. Such
forward-looking statements are based on the current beliefs of our
management as well as assumptions made by and information currently
available to them, which are subject to inherent uncertainties, risks
and changes in circumstances that are difficult to predict. Actual
outcomes and results may vary materially from these forward-looking
statements based on a variety of risks and uncertainties including: our
dependence on key management and product development personnel, our
dependence on our Grand Theft Auto products and our ability to
develop other hit titles, the timely release and significant market
acceptance of our games, the ability to maintain acceptable pricing
levels on our games, and risks associated with international operations.
Other important factors and information are contained in the Company’s
most recent Annual Report on Form 10-K, including the risks summarized
in the section entitled “Risk Factors,” the Company’s most recent
Quarterly Report on Form 10-Q, and the Company’s other periodic filings
with the SEC, which can be accessed at www.take2games.com.
All forward-looking statements are qualified by these cautionary
statements and apply only as of the date they are made. The Company
undertakes no obligation to update any forward-looking statement,
whether as a result of new information, future events or otherwise.

Contacts

Brian Roundy (Press)
Senior Manager
Communications
Private
Division

(646) 536-2936
[email protected]

Alan Lewis (Corporate Press)
Vice President
Corporate
Communications & Public Affairs
Take-Two Interactive
Software, Inc.

(646) 536-2983
[email protected]


Warning: Undefined array key 0 in /home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 493

Warning: Attempt to read property "cat_ID" on null in /home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 493

Cannabis

Cannabis Concentrate Market to Cross US$2.4 Billion by 2030 amid Rising Medical and Recreational Demand

Published

on

Continue Reading

transfer

IMC to transfer its Oranim Pharmacy shares back to the seller

Published

on

imc-to-transfer-its-oranim-pharmacy-shares-back-to-the-seller

TORONTO and GLIL YAM, Israel, April 16, 2024 /PRNewswire/ — IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) (the “Company” or “IMC“), a leading medical cannabis company with operations in Israel and Germany, is announcing that, further to the news release dated January 12, 2024, the Company has decided not to make remaining installment payments installments (i.e. NIS 5,873K including interest or 2,154K CAD) by IMC Holdings Ltd., and as such will transfer the 51% shares held by IMC Holdings Ltd back to the  seller.

“With the April 1st cannabis legalization in Germany, we are focusing our resources on the German market, where we expect to see the biggest growth potential,” said Oren Shuster, CEO of IMC. “With both of our core markets, Germany and Israel, currently undergoing rapid evolution, we need to assure that we allocate our resources to the growth opportunities where we expect the best return on investment.”

About IM Cannabis Corp.

IMC (Nasdaq: IMCC) (CSE: IMCC) is an international cannabis company that provides premium cannabis products to medical patients in Israel and Germany, two of the largest medical cannabis markets. The Company has recently exited operations in Canada to pivot its focus and resources to achieve sustainable and profitable growth in its highest value markets, Israel and Germany. The Company leverages a transnational ecosystem powered by a unique data-driven approach and a globally sourced product supply chain. With an unwavering commitment to responsible growth and compliance with the strictest regulatory environments, the Company strives to amplify its commercial and brand power to become a global high-quality cannabis player.

The IMC ecosystem operates in Israel through its commercial relationship with Focus Medical Herbs Ltd., which imports and distributes cannabis to medical patients, leveraging years of proprietary data and patient insights. The Company also operates medical cannabis retail pharmacies, online platforms, distribution centers, and logistical hubs in Israel that enable the safe delivery and quality control of IMC’s products throughout the entire value chain. In Germany, the IMC ecosystem operates through Adjupharm GmbH, where it distributes cannabis to pharmacies for medical cannabis patients. Until recently, the Company also actively operated in Canada through Trichome Financial Corp and its wholly owned subsidiaries, where it cultivated, processed, packaged, and sold premium and ultra-premium cannabis at its own facilities under the WAGNERS and Highland Grow brands for the adult-use market in Canada. The Company has exited operations in Canada and considers these operations discontinued.

Disclaimer for Forward-Looking Statements

This press release contains forward-looking information or forward-looking statements under applicable Canadian and U.S. securities laws (collectively, “forward-looking statements”). All information that addresses activities or developments that we expect to occur in the future are forward-looking statements. Forward-looking statements are often, but not always, identified by the use of words such as “seek”, “anticipate”, “believe”, “plan”, “estimate”, “expect”, “likely” and “intend” and statements that an event or result “may”, “will”, “should”, “could” or “might” occur or be achieved and other similar expressions. Forward-looking statements are based on the estimates and opinions of management on the date the statements are made. In the press release, such forward-looking statements include, but are not limited to,  the occurrence of growth opportunities and the likelihood of growth potential.

Forward-looking statements are based on assumptions that may prove to be incorrect, including but not limited to: the development and introduction of new products; continuing demand for medical and adult-use recreational cannabis in the markets in which the Company operates; the Company’s ability to reach patients through both e-commerce and brick and mortar retail operations; the Company’s ability to maintain and renew or obtain required licenses; the effectiveness of its products for medical cannabis patients and recreational consumers; and the Company’s ability to market its brands and services successfully to its anticipated customers and medical cannabis patients.

The above lists of forward-looking statements and assumptions are not exhaustive. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. Actual results may differ materially from those currently anticipated or implied by such forward looking statements due to a number of factors and risks. These include: any failure of the Company to maintain “de facto” control over Focus Medical in accordance with IFRS 10; the failure of the Company to comply with applicable regulatory requirements in a highly regulated industry; unexpected changes in governmental policies and regulations in the jurisdictions in which the Company operates; the effect of the reform on the Company; the Company’s ability to continue to meet the listing requirements of the Canadian Securities Exchange and the NASDAQ Capital Market; any unexpected failure to maintain in good standing or renew its licenses; the ability of the Company and Focus Medical (collectively, the “Group”) to deliver on their sales commitments or growth objectives; the reliance of the Group on third-party supply agreements to provide sufficient quantities of medical cannabis to fulfil the Group’s obligations; the Group’s possible exposure to liability, the perceived level of risk related thereto, and the anticipated results of any litigation or other similar disputes or legal proceedings involving the Group; the impact of increasing competition; any lack of merger and acquisition opportunities; adverse market conditions; the inherent uncertainty of production quantities, qualities and cost estimates and the potential for unexpected costs and expenses; risks of product liability and other safety-related liability from the usage of the Group’s cannabis products; supply chain constraints; reliance on key personnel; the risk of defaulting on existing debt and war, conflict and civil unrest in Eastern Europe and the Middle East

Any forward-looking statement included in this press release is made as of the date of this press release and is based on the beliefs, estimates, expectations and opinions of management on the date such forward-looking information is made.

The Company does not undertake any obligation to update forward-looking statements except as required by applicable securities laws. Investors should not place undue reliance on forward-looking statements. Forward-looking statements contained in this press release are expressly qualified by this cautionary statement.

Company Contacts:

Anna Taranko, Director Investor & Public Relations
IM Cannabis Corp.
+49 157 80554338
[email protected]

Oren Shuster, Chief Executive Officer
IM Cannabis Corp.
[email protected]

Logo – https://mma.prnewswire.com/media/1742228/IM_Cannabis_Logo.jpg

Cision View original content:https://www.prnewswire.co.uk/news-releases/imc-to-transfer-its-oranim-pharmacy-shares-back-to-the-seller-302117984.html

Continue Reading

Cannabis

Right on Brands Announces Major Product Line Expansion via HONEY® Brands

Published

on

Continue Reading

Trending on Grassnews

GrassNews.net: Your premier portal for the latest developments in the cannabis industry. We provide timely news, insightful analysis, and in-depth features on everything from legislation changes and business trends, to scientific research and lifestyle topics. Stay informed and navigate the rapidly evolving cannabis landscape with GrassNews.net..

Contact us: [email protected]

Editorial / PR Submissions

Copyright © 2007 - 2024 Hipther Agency. Registered in Romania under Proshirt SRL, Company number: 2134306, EU VAT ID: RO21343605. Office address: Blvd. 1 Decembrie 1918 nr.5, Targu Mures, Romania